Tracking recovery from C. diff infection in hospital patients
Part of Infections clinical trials.
This study follows patients with Clostridioides difficile (C. diff) infection to see how their symptoms improve and when the bacteria clear from their body. It aims to better understand recovery and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently hospitalized at GH Paris Saint-Joseph
- You have a confirmed C. diff infection or a repeat infection
- You are starting treatment for C. diff
- You speak French and agree to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry tracks people who receive a fecal microbiota transplant (FMT) for a serious or repeat C. diff infection. It helps doctors better understand how safe and effective FMT is in real-world use.
This study is tracking patients with a confirmed C. difficile infection to understand how the body responds and how treatments work. You may be asked to do follow-up visits for up to 5 years.
This study follows people who have a Clostridioides difficile infection to learn more about how the infection progresses and affects patients. By tracking symptoms and outcomes, researchers hope to improve future care.
This study gives healthy volunteers a specially prepared dose of Clostridioides difficile (C. diff), a bacteria that can cause diarrhea and gut problems, to learn how the infection develops. By participating, you may help researchers better understand and prevent C. diff infections in the future.
This study looks at levels of C. diff toxins in stool after standard antibiotic treatment. It aims to understand how toxins change during recovery, which may help improve future treatments for C. diff infections.
This trial compares three treatments for a severe diarrhea infection called C. diff: a fecal transplant (putting healthy donor stool into your gut), a newer antibiotic called fidaxomicin, and an older antibiotic called vancomycin. The goal is to see which works best and prevents the infection from coming back.
Hear when a new Clostridium Difficile Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.